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Summary
Objective: To identify subregional differences in femorotibial cartilage morphology between healthy controls and women with different grades
of radiographic knee osteoarthritis (OA).
Design: 158 women aged 40 years were studied. Weight-bearing extended anterior-posterior (AP) and Lyon schuss radiographs were ob-
tained and the Kellgren Lawrence grade (KLG) determined. 97 women had a body mass index (BMI) 28, no symptoms, and were AP KLG0.
61 women had a BMI 30, symptoms in the target knee, and mild (KLG2¼ 31) to moderate (KLG3¼ 30) medial femorotibial radiographic OA
in the AP views. Coronal spoiled gradient echo water excitation sequences were acquired at 3.0 Tesla. Total plate and regional measures of
cartilage morphology of the weight-bearing femorotibial joint were quantiﬁed.
Results: KLG2 participants displayed, on average, thicker cartilage than healthy controls in the medial femorotibial compartment (particularly
anterior subregion of the medial tibia (MT) and peripheral [external, internal] subregions of the medial femur), and in the lateral femur. KLG3
participants displayed signiﬁcantly thinner cartilage than KLG0 participants in the medial weight-bearing femur (central subregion), in the ex-
ternal subregion of the MT, and in the internal subregion of the lateral tibia. These differences were generally unaffected when possible effects
of demographic covariates were considered.
Conclusions: The results indicate that in femorotibial OA regional cartilage thickening and thinning may occur, dependent on the (radio-
graphic) disease status of the joint. These changes appear to display a heterogeneous spatial pattern, where certain subregions are more
strongly affected than others.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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1177Introduction
Osteoarthritis (OA) involves structural changes in several
tissues, those of cartilage and bone being most prevalent1.
Osteophytes (OP) and joint space narrowing (JSN) have
Table I
Demographics of the population studied and cartilage morphology
metrics (mean standard deviation) for groups with different KL
grades in the conventional weight-bearing extended AP
radiographs
AP KLG0
(n¼ 97)
AP KLG2
(n¼ 31)
AP KLG3
(n¼ 30)
Demographics
Age (y) 56.1 8.6 56.4 8.1 58.9 8.3
Height (cm) 165.5 6.9 163.1 6.1 163.0 7.4
Weight (kg) 68.0 13.5 94.7 14.8 101.4 16.4
BMI (kg/m2) 24.8 4.5 35.5 4.7 38.1 5.5
MT cartilage
MT.VC (mm3) 1774 294 2021 246 1812 386
MT.ThCtAB (mm) 1.62 0.17 1.75 0.15 1.58 0.20
MT.tAB (cm2) 10.9 1.1 11.5 0.8 11.3 1.4
MT.dAB NoPatients (%) 0 0 10
MT.dAB area (%) NA NA 2.5 1.6
cMT.ThCtAB (mm) 2.21 0.32 2.38 0.3 2.06 0.38
eMT.ThCtAB (mm) 1.37 0.16 1.45 0.15 1.23 0.19
iMT.ThCtAB (mm) 1.78 0.23 1.91 0.2 1.78 0.23
aMT.ThCtAB (mm) 1.40 0.18 1.57 0.15 1.39 0.23
pMT.ThCtAB (mm) 1.42 0.17 1.53 0.19 1.51 0.23
cMF
cMF.VC (mm3) 983 191 1104 190 928 231
cMF.ThCtAB (mm) 1.74 0.23 1.86 0.25 1.54 0.27
cMF.tAB (cm2) 5.3 0.7 5.6 0.5 5.7 0.9
cMF.dAB NoPatients (%) 1 0 27
cMF.dAB area (%) 6.1 NA 9.3 9.7
ccMF.ThCtAB (mm) 2.10 0.31 2.17 0.36 1.69 0.46
ecMF.ThCtAB (mm) 1.28 0.19 1.45 0.22 1.18 0.26
icMF.ThCtAB (mm) 1.85 0.26 1.99 0.31 1.75 0.27
LT cartilage
LT.VC (mm3) 1908 369 1963 329 1865 385
LT.ThCtAB (mm) 1.98 0.27 1.98 0.29 1.90 0.27
LT.tAB (cm2) 9.3 1.0 9.6 0.9 9.5 1.3
LT.dAB NoPatients (%) 0 10 17
LT.dAB area (%) NA 2.1 1.1 2.9 0.4
cLT.ThCtAB (mm) 3.00 0.56 2.83 0.71 2.81 0.59
eLT.ThCtAB (mm) 1.57 0.23 1.64 0.2 1.58 0.22
iLT.ThCtAB (mm) 1.89 0.28 1.81 0.35 1.72 0.32
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OA (ROA)2e5. Although JSN is often viewed as a surrogate
of cartilage thinning, it is confounded by meniscal patholo-
gy6e8, and it only correlates with cartilage in the medial,
but not in the lateral femorotibial compartment9. It has
been reported that a substantial portion of subjects with nor-
mal radiographs displayed advanced OA at arthroscopy,
whereas femorotibial JSN was common in participants
with normal cartilage status at arthroscopy5.
Magnetic resonance imaging (MRI) permits one to grade
cartilage lesions and thinning throughout the knee1,10,11,
and also provides accurate quantitative data on cartilage
morphology12e14. A cross-sectional MRI study in a conve-
nience sample of 372 subjects15 found that subjects withme-
dial JSN (predominantly grade 1; N¼ 50; 71% women)
displayed a 11e13% lower cartilage volume (VC) of the me-
dial tibia (MT) and lateral tibia (LT) than those without JSN
(n¼ 316; 56% women), but no difference in tibial subchon-
dral bone size. No signiﬁcant difference in VC was found be-
tween subjects with (predominantly grade 1; N¼ 19; 26%
women) and without OP, but a 10e16% greater tibial cross-
sectional area. Burgkart and coworkers16 showed that for
the effective discrimination of cartilage morphology status
between OA patients and healthy subjects, the VC must be
normalized to the subchondral bonearea, or that the cartilage
thickness must be measured throughout the entire subchon-
dral bone (ThCtAB) including denuded areas.
Subregional analysis of cartilage morphology has recently
been introduced, to characterize the spatial variation of carti-
lage changes in OA17e19, and longitudinal studies have sug-
gested that cartilage loss is most pronounced in central
femorotibial subregions18,20. However, it is currently unknown
to what extent subregional cartilage morphology differs be-
tween subjects with different grades of symptomatic ROA
and healthy controls. Therefore we here test the hypothesis
that cartilagemorphology isaffected todifferent extents in fem-
orotibial subregionsbyROAstatus, and that the spatial pattern
of the differences with healthy controls differs between Kellg-
ren Lawrence grade (KLG) 2 and KLG3 participants.aLT.ThCtAB (mm) 1.62 0.21 1.76 0.23 1.61 0.28
pLT.ThCtAB (mm) 1.90 0.34 1.91 0.31 1.81 0.3
cLF
cLF.VC (mm3) 1031 198 1141 180 1123 232
cLF.ThCtAB (mm) 1.70 0.23 1.89 0.23 1.83 0.28
cLF.tAB (cm2) 5.9 0.7 5.8 0.6 5.9 0.9
cLF.dAB NoPatients (%) 1 10 20
cLF.dAB area (%) 0.7 4.1 3.9 6.8 3.2
ccLF.ThCtAB (mm) 2.04 0.33 2.27 0.34 2.2 0.37
ecLF.ThCtAB (mm) 1.49 0.22 1.68 0.23 1.65 0.29
icLF.ThCtAB (mm) 1.6 0.2 1.77 0.23 1.67 0.28
MT¼medial tibia; cMF¼ central (weight-bearing) medial femoral
condyle; LT¼ lateral tibia; cLF¼ cMF¼ central (weight-bearing)
lateral femoral condyle; c¼ central; e¼ external; i¼ internal;
a¼ anterior; p¼ posterior subregion; ThCtAB¼mean thickness of
cartilage over the tAB (including denudedareas countingas 0 mmcar-
tilage thickness); dAB¼ denuded area of subchondral bone; NoPa-
tients¼ number of patients with dABs (in %); dAB area¼ area of
dAB in % of tAB in those participants that have dAB; NA¼ not
applicable.Methods
In this cross-sectional sub-study of the baseline data of a longitudinal in-
vestigation (A9001140), 180 female participants, aged 40 years, were re-
cruited at seven clinical centers21. The analysis of the baseline MR images
was performed in pairs with 3 month follow-up images. Only the baseline
data were used for this cross-sectional analysis, and the 3 month data
have been reported previously21. Twenty-two participants were not included
in the analysis as described earlier21.
Conventional weight-bearing extended anterior-posterior (AP) knee radio-
graphs and posterior-anterior (PA) Lyon schuss (LS) radiographs22e24 were
obtained at baseline, to establish the KLG status. Inclusion criteria for OA
participants were frequent symptoms, mild to moderate ROA in the medial
femorotibial compartment (KLG2 or 3) in the AP view, less JSN in the lateral
than in the medial femorotibial compartment, a body mass index (BMI) of
30, and a medial femorotibial joint space width of 2 mm in the PA LS
view. In patients with bilateral ROA, the more symptomatic knee was se-
lected. If pain scores were identical in both knees, the one with the higher
KLG was chosen. If these were also identical, the dominant limb was se-
lected. Healthy controls needed to show a complete absence of knee symp-
toms, no evidence of ROA (KLG 0), a BMI of 28, and were age-matched to
within 5 years of OA participants. In the healthy controls, the dominant leg
was selected. An experienced central reader (St.M), who was blinded to
the KLG readings of the clinical centers, re-read all AP radiographs after en-
rollment was completed. If the grade assigned differed from that of the site
readings, the difference was adjudicated by a third reader (KB)21. After adju-
dication, 97 participants were KLG0, 31 KLG2, and 30 KLG3 (AP views). The
demographics of the participants is presented in Table I. Four participants
were KLG1 and were not included in the analysis. The LS radiographs24
were taken in about 20 knee ﬂexion and were additionally used for the KL
grading, because they were previously found superior to conventional AP
views in detecting JSN22,23. However, results will be provided for both theLS and AP views, because AP views have been more commonly used in
other studies and are the radiographic method in which the KL grades
were originally deﬁned. The LS radiographs were read by two experienced
readers (EV and MP); if the grades assigned differed, the difference was ad-
judicated by a third reader (MPHLG). Of the 158 participants, 82 participants
were KLG0, 3 KLG1, 32 KLG2, and 41 KLG3 in the LS views. No attempt
was made to establish a deﬁnite KL grade based on the combined LS and
AP views, but readings from both views were treated separately and used
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were allowed to take have been described previously21. The study was con-
ducted in compliance with the ethical principles derived from the Declaration
of Helsinki and in compliance with local Institutional Review Board, informed
consent regulations, and International Conference on Harmonization Good
Clinical Practices Guidelines.
Three of the seven imaging sites used Magnetom Trio magnets (Siemens
AG, Erlangen, Germany) and four Signa Excite/Genesis Signa magnets, two
short bore and two long bore (GE Healthcare Technologies, Waukesha, WI).
Double oblique coronal spoiled gradient recalled acquisition at steady state
(SPGRorFLASH) sequenceswith selectivewater excitationwereacquiredus-
ing birdcage circumferentially polarized (CP) coils21,25. Images were collected
with 16e17 ms repetition time (TR), 7e8 ms echo time (TE), 12 ﬂip angle (a),
1 mm partition thickness, and 0.31 mm 0.31 mm in-plane resolution21. A
phantom (Data SpectrumCorp., Chapel Hill, NC) was scanned at each patient
visit to ensure geometric accuracy and stability of the measurements.
The MR images were then sent to the image analysis center (Chondro-
metrics GmbH, Ainring, Germany), where they were processed using cus-
tomized software. Segmentation of the femorotibial cartilages was
performed by seven technicians with formal training and 3 years experi-
ence in cartilage segmentation. The subchondral bone interface and cartilag-
inous joint surface area of the MT, LT, central (weight-bearing) medial
femoral (cMF) and central lateral femoral (cLF)26 cartilage plate were traced
manually (Fig. 1)21,25. Quality control of all segmentations was performed by
one person (FE), reviewing all segmented slices. The segmentations were
used to compute the total area of subchondral bone (tAB), the part of the
tAB covered by cartilage (cAB) and not covered by cartilage (denu-
ded¼ dAB), respectively, the VC, the mean cartilage thickness over the
cAB (ThCcAB), and the mean cartilage thickness over the tAB (ThCtAB), in-
cluding denuded areas (¼0 mm cartilage thickness)26,27. The precision and
stability of the measurements in this multicenter, multivendor study have
been reported previously21.
Then the subregional algorithms developed by Wirth and Eckstein19 were
applied to the tibial and femoral cartilage plates, to compute ThCtAB in ﬁve
tibial (central, external, internal, anterior, and posterior) and in three femoral
subregions (central, external, internal). The central tibial subregions (cMT,
cLT) occupied 20% and the central femoral subregions (ccMF and ccLF)
33% of the tAB, respectively19 (Fig. 1).
Mixed effects models, with a random intercept and variance parameters for
each of the KL groups were used for statistical modeling and analysis. Fixed
effects in the model included the KL group (either AP KLG or LS KLG) and
one or more of four covariates: age, height, weight, and BMI. Based on maxi-
mum likelihood estimates for the models, analysis of variance (ANOVA) was
used to select covariates for inclusion in the ﬁnal statistical model. While indi-
cations for the best model may vary with the speciﬁc cartilage morphology pa-
rameter being assessed, a single model, i.e., single set of covariates with KL
group, was used across all cartilage morphology parameters. The choice of
the model was based on which covariates were most important across most
cartilage morphology parameters. The inclusion/exclusion for a covariate
was based on whether it was signiﬁcant after KL group was included in the
model. Notably, BMI constituted part of the selection status of OA participants
and healthy controls and so was highly confounded with KL status. To ensure
that differences between KL groups were due to KLG and not to a covariate,
tests for KL group were performed after including the speciﬁed covariate in
themodel. Also, testswere carried out to determinewhether covariates had dif-
ferent relationships (slopes) in the KL groups. False discovery rate methods
were used to adjust for multiple comparisons, a¼ 0.1. Percent differences in
cartilage morphology metrics between KLG2 or KLG3 and KLG0 were based
on difference estimates from the mixed effects models divided by the mean
value across all subjects for the relevant cartilage morphology parameter.
Results
The demographic and cartilage morphology data for
healthy controls (AP KLG0) and subjects with AP KLG2
and KLG3 ROA are summarized in Table I. As per study de-
sign, the mean age was similar between KL groups, while
BMI and weight were substantially different between the
ROA groups and the healthy controls. Height turned out
to be signiﬁcantly different between the ROA groups and
the healthy controls (P< 0.0001), but the differences were
relatively small (<2.5 cm). Most of the difference in BMI be-
tween KL groups was thus due to a difference in weight.TESTS FOR INCLUSION OF COVARIATES IN THE COMPARISON
OF THE KL GROUPSGiven the study design and inclusion criteria, BMI was of
particular concern as a covariate. Tests for different slopesfor BMI in different AP KL groups were not signiﬁcant for
any cartilage morphology metric, and only a few results in
the lateral femur (cLF) were signiﬁcant, when LS KL grades
were used. No tests were signiﬁcant for BMI after adjusting
for KL group (either AP or LS), while most of the medial
compartment measurements had signiﬁcant differences in
KL group (AP or LS) after adjusting for BMI. Some lateral
compartment measurements (AP or LS) also showed signif-
icant differences between KL groups after adjusting for BMI.
These results indicate that differences observed between
KL group are likely not due to differences in BMI.
Both weight and height showed signiﬁcant differences be-
tween APKL groups. Slopes for height or weight were not sig-
niﬁcantly different between AP KL groups, but were
signiﬁcantly different for some cartilage morphology metrics
between LS KL groups. A large number of cartilage variables
displayed signiﬁcant relationship with height and/or weight af-
ter adjusting for KL group (AP or LS). Given that height and
weight are correlatedwith eachother, testswere applied tode-
termine if eitherwasmorehelpful inexplainingvariability incar-
tilage morphology metrics. After adjusting for height (and KL
group), tests for weight were not signiﬁcant for any cartilage
morphology metric, while tests for height were signiﬁcant for
most variables after adjusting for weight (both for AP and LS
KL groups). Age showed no differences in slope and few sig-
niﬁcant tests after adjusting for KL group, while many cartilage
metrics were signiﬁcant when including KL group (AP or LS)
after adjusting for age.Basedon these results, estimatesofdif-
ferences between KL groups for the cartilage variables were
providedasunadjustedpercent differencesandaspercent dif-
ferences adjusted for body height.TOTAL AREAS AND DENUDED AREAS OF SUBCHONDRAL
BONECompared with the healthy controls, the KLG2 partici-
pants displayed signiﬁcantly larger tABs in MT, cMF and
LT (range þ3.6% to þ5.9%), when not adjusting for cova-
riates (Table II). KLG3 participants also showed larger
tABs in the medial femorotibial compartment (þ3.7 to
6.4%; Table II). When adjusting for height (Table III), differ-
ences in tAB between KLG2 and KLG0 increased (range
þ5.7 to þ7.4%) and became signiﬁcant for cLF (þ3.4%;
LS view). Similar observations were made between
KLG3 and KLG0, with differences in tAB increasing up to
8.5% (Table III).
Very few of the AP KLG0 and AP KLG2 participants dis-
played denuded subchondral areas (dAB¼ full thickness
cartilage defects) in the medial femorotibial compartment
(with the exception of one AP KLG0 participant in cMF),
but 10% of the AP KLG3 participants did show a dAB in
MT, and 27% in cMF (Table I). One AP KLG0 participant
displayed a relatively small dAB in cLF, but 10% of the
AP KLG2 did in LT and cLF, 17% of the AP KLG3 partici-
pants did in LT and 20% did in cLF (Table I). The size of
the denuded area (in those with denuded areas) in AP
KLG3 participants varied from 2.5 1.6% (of the tAB) in
MT to 9.3 9.7% in cMF (Table I). Using the LS view,
none of the LS KLG0 participants displayed a denuded sub-
chondral bone area, but 3% (MT) to 16% (LT and cLF) of
the LS KLG2 participants, and 5% (MT) to 17% (cMF) of
the LS KLG3 participants did (data not shown).TOTAL PLATE CARTILAGE THICKNESSThe variability (standard deviation) of the cartilage thick-
ness was similar for the different KL grades (Table I), but
Fig. 1. Depiction of the femorotibial subregions: (A) Coronal MR image showing the femorotibial cartilages. (B) Posterior view of femorotibial
cartilages (tibia at the bottom, weight-bearing femur at the top). (C) Superior view of the tibial cartilages. MT¼medial tibia; cMF¼ central
(weight-bearing) medial femoral condyle; LT¼ lateral tibia; cLF¼ cMF¼ central (weight-bearing) lateral femoral condyle; ccMF¼ central
cMF, ecMF¼ external cMF, icMF¼ internal cMF, eMT¼ external MT, iMT¼ internal MT, aMT¼ anterior MT, pMT¼ posterior MT (the
same abbreviations are used for cLF and LT).
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ferences without adjustment for any variable (Table II) and
with adjustment for height (Table III) were generally simi-
lar, whilst the adjustment for height increased the differ-
ences slightly. Only adjusted differences will be
presented below.KLG2 participants (both AP and LS) displayed on average
thicker cartilage (ThCtAB and ThCcAB) than healthy (KLG0)
participants in MT, cMF and cLF (P< 0.01; range þ9 to
þ13%), but not in LT (Table III). KLG3 participants displayed
signiﬁcantly thinner cartilage in cMF (6 to 10%; Table III),
but thicker cartilage than KLG0 participants in cLF (þ9 to
Table II
Non-adjusted differences (in percent¼%) from healthy controls in
cartilage morphology metrics between groups with different KL
grades in the conventional weight-bearing extended AP radio-
graphs and in the LS radiographs. Negative signs indicate a smaller
value than for healthy (KLG0) control participants
AP KLG2
(n¼ 31)
AP KLG3
(n¼ 30)
LS KLG2
(n¼ 32)
LS KLG3
(n¼ 41)
MT.VC 13.9*** 2.2 14.0*** 7**
MT.ThCtAB 8.4*** 2.1 8.3*** 0.3
MT.ThCcAB 8.4*** 1.8 8.3*** 0.5
MT.tAB 5.6*** 3.7 5.4*** 6.2***
cMT.ThCtAB 8.0*** 6.4* 9.7*** 4.8
eMT.ThCtAB 6.4*** 10.0*** 6.3** 8***
iMT.ThCtAB 7.6*** 0.1 8.5*** 3.4
aMT.ThCtAB 11.7*** 1.3 11.4*** 2.2
pMT.ThCtAB 7.4*** 6.2* 4.7* 8.2***
cMF.VC 12.4*** 5.6 14.9*** 3.8
cMF.ThCtAB 7.3** 11.5*** 8.6*** 8***
cMF.ThCcAB 7.2** 9.5*** 9.2*** 6.8**
cMF.tAB 4.6** 6.4** 5.6** 4.3
ccMF.ThCtAB 3.4 19.6*** 5.6* 16.2***
ecMF.ThCtAB 13.0*** 7.9* 10.7*** 4.5
icMF.ThCtAB 7.5** 5.6* 10.3*** 2.0
LT.VC 2.9 2.2 6.4 1.9
LT.ThCtAB 0.2 4.3 1.0 5.0*
LT.ThCcAB 0 3.9 1.4 4.9*
LT.tAB 3.6* 2.5 5.9*** 3.7
cLT.ThCtAB 5.6 6.1 2.3 7.7**
eLT.ThCtAB 4.1 0.6 7.4*** 2.2
iLT.ThCtAB 4.4 9.2*** 3.4 10.1***
aLT.ThCtAB 8.3*** 0.9 6.2* 2.7
pLT.ThCtAB 0.1 4.7 0.2 6.4**
cLF.VC 10.7*** 8.9* 13.3*** 9.5**
cLF.ThCtAB 11.4*** 7.6** 11.4*** 9.6***
cLF.ThCcAB 11.8*** 8.8*** 12.2*** 10.2***
cLF.tAB 1.0 0.6 1.0 0.6
ccLF.ThCtAB 11*** 7.7** 11.6*** 10.7***
ecLF.ThCtAB 12.8*** 10.8*** 14.5*** 12.1***
icLF.ThCtAB 10.7*** 4.6 8.4** 6**
ThCcAB¼mean thickness of cartilage over cartilage-covered
area of subchondral bone, not including denuded areas; other ab-
breviations and units are the same as in Table I. *P< 0.1;
**P< 0.05; ***P< 0.01.
Table III
Differences (in percent¼%) from healthy controls in cartilage mor-
phology metrics between groups with different KL grades in the
conventional weight-bearing extended AP radiographs and in LS
radiographs with adjustment for body height. Negative signs indi-
cate a smaller value than for healthy (KLG0) control participants
AP KLG2
(n¼ 31)
AP KLG3
(n¼ 30)
LS KLG2
(n¼ 32)
LS KLG3
(n¼ 41)
MT.VC 17.1*** 5.4 15.8*** 9.1***
MT.ThCtAB 9.7*** 0.7 8.7*** 1.5
MT.ThCcAB 9.7*** 0.4 8.8*** 1.7
MT.tAB 7.4*** 5.6** 7*** 6.8***
cMT.ThCtAB 9.7*** 4.7 9.6*** 3.5
eMT.ThCtAB 7.6*** 8.7*** 8.4*** 5.7***
iMT.ThCtAB 9.4*** 2.0 9.8*** 4.7**
aMT.ThCtAB 12.5*** 0.4 12.3*** 4.5*
pMT.ThCtAB 8.5*** 7.4** 5.3** 8***
cMF.VC 16*** 1.9 17.4*** 1.3
cMF.ThCtAB 8.8*** 9.9*** 9*** 6.4**
cMF.ThCcAB 8.8*** 7.8*** 9.4*** 5.9**
cMF.tAB 6.6*** 8.5*** 5.9*** 3.0
ccMF.ThCtAB 5.0 17.9*** 4.6 13.4***
ecMF.ThCtAB 14.5*** 6.4* 9.2*** 2.1
icMF.ThCtAB 8.8*** 4.2 10.9*** 0.8
LT.VC 5.6 0.6 6.1* 1.1
LT.ThCtAB 0.5 3.7 1.0 4.9*
LT.ThCcAB 0.7 3.2 1.4 4.7*
LT.tAB 5.7*** 4.6** 5.9*** 4.7**
cLT.ThCtAB 5.0 5.5 3.0 6.5*
eLT.ThCtAB 5.5** 2.0 7.1*** 1.5
iLT.ThCtAB 3.9 8.6** 3.1 9.2***
aLT.ThCtAB 8.9*** 0.3 6.9** 3.1
pLT.ThCtAB 0.7 4.2 0.4 6.1*
cLF.VC 14.1*** 12.4*** 15.4*** 9.3***
cLF.ThCtAB 12.6*** 8.8** 12.4*** 9.2***
cLF.ThCcAB 13.0*** 10.1*** 13.0*** 10.0***
cLF.tAB 1.1 2.8 3.4** 1.4
ccLF.ThCtAB 12.6*** 9.3** 12.6*** 10.8***
ecLF.ThCtAB 14.0*** 12.0*** 16.8*** 11.0***
icLF.ThCtAB 11.5*** 5.5 8.5*** 4.9*
ThCcAB¼mean thickness of cartilage over cartilage-covered
area of subchondral bone, not including denuded areas; other ab-
breviations and units are the same as in Table I. *P< 0.1;
**P< 0.05; ***P< 0.01.
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KLG3 and KLG0 participants was slightly greater than for
ThCcABand itwas substantially greater than forVC (Table III).SUBREGIONAL CARTILAGE THICKNESSThe differences in cartilage thickness of KLG2 vs KLG0
participants in MT were greatest in the anterior subregion
(þ12% after adjusting for height; Table III), but relatively
uniform across the subregions (Fig. 2). In cMF, the greatest
difference in thickness between KLG2 vs KLG0 was in the
external (AP þ15%) and internal subregion (AP þ9%) and
was less in the central subregion (Table III; Fig. 2). In cLF,
all subregions displayed relatively large differences in thick-
ness (þ9 to þ17%) vs KLG0 (both in AP and LS).
The differences in cartilage thickness for cMF between
AP KLG3 and KLG0 participants were greatest in the cen-
tral subregion (18% AP, 13% LS; Table III; Fig. 2),
with the other subregions displaying smaller differences.
Although the cartilage thickness across the entire MT was
not signiﬁcantly different between KLG3 and KLG0, the ex-
ternal tibial subregion displayed signiﬁcantly thinnercartilage in KLG3 participants (9% in AP and 6% in
LS; Table III; Fig. 2), while the posterior subregion showed
thicker cartilage than in KLG0 participants (þ7% in AP and
þ8% in LS). In the LT, the internal subregion displayed the
greatest difference in cartilage thickness in KLG3 vs KLG0
participants (9% in AP and LS; Table III).Discussion
The rationale for this study was to identify whether carti-
lage morphology is affected to different extents throughout
anatomically deﬁned femorotibial subregions by ROA sta-
tus, and whether the spatial pattern of the differences with
healthy controls differs between KLG2 and KLG3 partici-
pants. Limitations of the study include that only women
were studied and that the number of participants was rela-
tively small, in particular those with ROA. Statistical testing
was therefore conﬁned to differences between KLG2 or
KLG3 vs KLG0 participants, but did not involve an analysis
of signiﬁcant differences between cartilage plates/subre-
gions, or between the AP and LS radiographs. Also, the ob-
servations apply to participants with ROA who display
Fig. 2. Bar graphs showing percent differences in cartilage thickness (ThCtAB) adjusted for body height in subregions of the medial femoroti-
bial compartment between participants with KLG2 and healthy KLG0 participants (top) and between KLG 3 and healthy KLG0 participants
(bottom), based on conventional weight-bearing extended anterioeposterior X-rays: *P< 0.1, **P< 0.05, ***P< 0.01 (difference signiﬁcant
compared with healthy control KLG0 participants). MT¼medial tibia; cMF¼ central (weight-bearing) medial femoral condyle.
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however, showed that BMI was not a signiﬁcant covariate
of the differences in cartilage morphology between KLG
groups, and after adjustment for BMI the results were very
similar to those before adjustment (data not shown). It has
been shown previously that body height is highly correlated
with tAB, in particularly in women28, and our tests conﬁrmed
that height was a signiﬁcant covariate. Nevertheless, the
differences in cartilage thickness between KL groups before
and after adjustment for height were found to be similar.
Key ﬁndings of the study are: (1) the number of partici-
pants with full thickness lesions (denuded area> 0%) in-
creased with higher KLG. The proportion of lateral lesions
was similar to that of medial lesions, albeit the KLG3 partic-
ipants were selected to have primarily medial JSN; (2) both
the KLG2 and KLG3 participants displayed signiﬁcantly
larger subchondral bone areas (tABs) in most cartilage
plates than the healthy control participants (KLG0); (3)
KLG2 participants displayed on average signiﬁcantly thicker
cartilage compared with KLG0 healthy controls in the me-
dial femorotibial compartment (mainly anterior subregion
of MT and peripheral [external and internal] subregions of
cMF), and in the lateral femur (mainly external subregion);
(4) KLG3 participants displayed signiﬁcantly thinner carti-
lage in the medial weight-bearing femur compared with
KLG0 participants, the difference being greatest in the cen-
tral subregion of the medial femur. In the MT, the external
subregion displayed a signiﬁcantly lower cartilage thickness
in KLG3 participants, whereas a signiﬁcant thicker cartilage
was observed in the posterior subregion compared with
KLG0 participants.Jones et al.15 previously reported signiﬁcantly (10e16%)
larger tibial cross-sectional area in persons with OP com-
pared to those without OP, but no differences in the
cross-sectional areas between persons with and without
JSN. In contrast, we ﬁnd greater subchondral bone areas
(tABs) in participants with OP or with JSN compared with
those without. Note that all efforts were made to exclude
OP from segmentations of the subchondral bone area, so
that differences in tAB should not be due to the existence
of OP. However, the increase in tAB may be due to (re)-
modeling of the bone in OA, potentially in response to an in-
creased mechanical stress. It is important to note that the
osteophyte subcohort examined by Jones et al.15 contained
predominantly men, and their JSN subcohort predominantly
women; this may have biased the values toward larger and
smaller bone size, respectively29,30. A longitudinal study31
in OA participants found the MT bone area to increase by
2.2 6.9% per year, a higher BMI and a higher baseline
grade of medial JSN being positively associated with an in-
creased rate of enlargement.
The greater cartilage thickness in KLG2 vs KLG0 partici-
pants was not observed in the study by Jones et al.15. In the
Framingham cohort, Reichenbach et al.32 recently reported
higher semi-quantitative scores (reﬂecting focal cartilage
changes) in participants with mild ROA (KLG2) compared
with those without OA, but no signiﬁcant differences in total
plate cartilage thickness. Our ﬁndings are in agreement with
previous X-ray data in the same cohort studied here24,
which showed a signiﬁcantly greater medial minimal JSW
in KLG2 than in KLG0 participants, and a signiﬁcantly
smaller medial minimal JSW in KLG3 than in KLG0
1183Osteoarthritis and Cartilage Vol. 17, No. 9participants. This observation is important, because the X-
rays were taken during weight-bearing, but MRI was not.
Despite the mechanical compression of the potentially
‘‘softer’’ cartilage, however, the JSW was still greater in
KLG2 vs KLG0 participants when assessed from weight-
bearing X-rays. Taken together, these ﬁnding indicate that
cartilage thickening (e.g., hypertrophy/swelling) may occur
particularly in early ROA (KLG2), as has been suggested
by various animal models33e37. In these models, cartilage
hypertrophy was shown to precede cartilage breakdown,
but also to persist in parallel when tissue loss occurred
later. An increase in cartilage thickness has also been ob-
served using MRI in patients after acute injury of the ante-
rior cruciate ligament38. This may represent traumatic
chondral edema or be a sign of early OA.
In the current study, thicker cartilage was observed on
average in obese KLG2 participants. Recently, Hunter
et al.39 reported that the cartilage thickness was similar or
greater in knees without ROA, when ROA was present in
the contralateral knee, compared to non-ROA knees of
which the contralateral knee was also free of ROA. The au-
thors concluded that cartilage thinning does not represent
the initial pathological cartilage change in OA, and our cur-
rent ﬁndings support this observation. Moreover, our results
indicate that cartilage thickening is most pronounced in the
anterior aspect of the MT and in the peripheral (external and
internal) subregions of the medial femoral condyle. In the
cases examined here, the lateral femur, but not the LT dis-
played a greater cartilage thickness in KLG2 than in KLG0
participants.
Cartilage thinning was detected in the medial femur of
KLG3 participants with medial JSN, although only subjects
with a JSW of greater than 2 mm (LS view) were included.
Jones et al.15 previously also reported a signiﬁcantly
smaller tibial VC (but similar tibial cross-sectional area) in
persons with grade 1 vs no JSN. The differences in total
MT cartilage thickness between KLG3 and KLG0 were rel-
atively small in our study, but differences were greater in the
external (AP and LS view) and central MT (AP only),
whereas a signiﬁcantly greater thickness was observed in
the posterior subregion of MT in KLG3 knees. Similar to
Jones et al.15, we observed a signiﬁcantly lower cartilage
thickness in LT, which mainly involved its internal aspect.
Differences in ThCtAB (cartilage thickness including de-
nuded areas as 0 mm cartilage thickness) and ThCcAB
(cartilage thickness not including denuded area) between
KLG3 and KLG0 were relatively minor, because few partic-
ipants displayed denuded areas. However, the differences
(discrimination) for ThCtAB and ThCcAB were greater
than for VC (which did not show a signiﬁcant difference be-
tween KLG3 and KLG0 participants). This has also been
shown previously in patients prior to total knee arthro-
plasty16, likely because VC is more variable between sub-
jects than cartilage thickness, given inter-individual
differences in bone size.
Compared with the extended AP and other views, LS
views22e24 achieve better alignment of the MT plateau
with the X-ray beam, enhancing the ability to detecting me-
dial (and lateral) JSN23. We had therefore expected the LS
KLG3 participants to display greater differences compared
with LS KLG0 controls than AP KLG3 compared with AP
KLG0 participants, but the differences in cartilage thickness
were similar for both radiographic techniques. The number
of subjects with a difference in KLG3 scores between LS
and AP differed only by n¼ 11, which may have been too
few cases to reveal a difference between both methods.
Also, the AP radiographs were acquired with the knee fullyextended, but LS radiographs with the knee in approxi-
mately 20 ﬂexion. This difference in femoral condyle posi-
tioning relative to the tibial plateau may account for slight
differences with the weight-bearing femoral regions ana-
lyzed using MRI. Lastly, medial JSW not only depends on
cartilage thickness, but also on medial meniscus pathology
and extrusion6e8, and this may have different effects in the
extended AP and in the 20 ﬂexed LS X-rays. Results
based on grading by other radiographic techniques, such
as ﬁxed ﬂexion40, may however yield different results from
those presented here, as different techniques have different
ability to demonstrate JSN23,24.
In conclusion, we ﬁnd that KLG2 obese participants
displayed on average thicker cartilage than healthy non-
overweight women, mainly in the medial femorotibial
compartment, both before and after adjustment for body
height. The increase was most pronounced in the anterior
subregions of the MT and in the peripheral (external and
internal) subregions of the medial weight-bearing femur.
Obese KLG3 participants, in contrast, displayed signiﬁ-
cantly thinner cartilage than healthy non-overweight con-
trols, with the reductions being most pronounced in the
central subregions of the medial femur, the external sub-
region of the MT, and the internal subregion of the LT.
The results indicate that in femorotibial OA regional carti-
lage thickening and thinning may occur, dependent on
the (radiographic) disease status of the joint. These
changes appear to display a heterogeneous spatial pat-
tern, where certain subregions are more strongly affected
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